— Know what they know.
Not Investment Advice
Also trades as: ORPHA.CO (CPH) · $vol 0M · ORPHY (OTC) · $vol 0M · 0CUM.L (LSE) · $vol 0M

ORPH NASDAQ

Orphazyme A/S
1W: -2.5% 1M: -29.3% 3M: -65.3% 1Y: -89.6%
$0.87
Last traded 2022-03-30 — delisted
NASDAQ · Healthcare · Biotechnology

Balance Sheet Trends

Total Assets
$19M -66.0% ▼
5Y CAGR: -46.5%
Total Liabilities
$5M -68.0% ▼
5Y CAGR: -37.5%
Shareholders Equity
$14M -65.2% ▼
5Y CAGR: -48.4%
Cash & Investments
$18M -53.2% ▼
5Y CAGR: -45.9%
Total Debt
$0 +0.0% ▲
Net Debt
-$11M +71.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$124M$727M$102M$39M$11M
Short-Term Investments$0$0$0$0$7M
Cash & ST Investments$124M$727M$102M$39M$18M
Net Receivables$11M$18M$44M$4M$1M
Inventory$0$0$0$0-$1K
Other Current Assets$0$0$0$14M$0
Total Current Assets$148M$784M$159M$57M$19M
Property, Plant & Equip.$18M$20M$8M$0$0
Goodwill & Intangibles$11M$12M$2M$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$4M$5M$4M$0$0
Total Non-Current Assets$33M$39M$14M$0$0
Total Assets$181M$822M$173M$57M$19M
— Liabilities —
Accounts Payable$1M$30M$42M$4M$5M
Short-Term Debt$13M$33M$31M$0$0
Deferred Revenue$95K$0$46M$0$0
Other Current Liabilities$63M$0$584K-$4M-$5M
Total Current Liabilities$66M$167M$129M$16M$5M
Long-Term Debt$52M$24M$2M$0$0
Other Non-Current Liab.$378K$2M$28M$99K$0
Total Non-Current Liabilities$62M$35M$35M$99K$0
Total Liabilities$128M$202M$164M$16M$5M
— Equity —
Common Stock$20M$35M$35M$35M$12M
Retained Earnings-$899M-$1.5B-$2.1B-$2.1B$2M
Accumulated OCI$8M$6M$3M-$303K$0
Total Stockholders Equity$53M$621M$9M$41M$14M
Total Liabilities & Equity$181M$822M$173M$57M$19M
— Key Metrics —
Total Debt$77M$71M$40M$0$0
Net Debt-$46M-$656M-$62M-$39M-$11M
Total Investments$0$0$0$0$7M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms